Outcome of Board Meeting

Ind-Swift Laboratories Limited A, Registered Office )‘ SCO 850, Shivalik Enclave, o Chan-d 16i01g01 aWDh/A !.':.,fl:.,fiwi.'.;f,]; 52 info@indswiftlabs.com One World One Health One ind-Swift Q@ 0172-2730508, 2730920, 5061851-53 CIN No. L24232CH1995PLC015553 Ref: ISLL:CH:2026 Date: 29 October, 2026 The President The Vice President, Corporate Relationship Department Listing Compliance Department, BSE Limited National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, Exchange Plaza, 5 Floor 25% Floor, Dalal Street, Plot No. C/2, G-Block, Mumbai 400 001 Bandra Kurla Complex, Bandra (E), Mumbai 400 051 BSE Scrip Code: 532305 NSE Symbol: INDSWFTLAB SUB: OUTCOME OF BOARD MEETING Dear Sir/Ma’am, Pursuant to Regulation 30, Regulation 33 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations™), we hereby inform that the Board of Directors of the Company, at its meeting held today, i.e., Thursday, October 29, 2026, has, inter alia, considered and approved the following: 1. Standalone and Consolidated Un-Audited Financial Results of the Company for the quarter and six months ended September 30, 2026, along with the Limited Review Reports issued by the Statutory Auditors. A copy of the Financial Results together with the Limited Review Reports is enclosed herewith as Annexure I. The said financial results shall also be made available on the Company’s website at www.indswiftgroup.convinvestor. The Board Meeting commenced at 12:00 P.M and concluded at 02:45 P.M. You are requested to kindly take the same on record. Thanking you, For IND-SWIFT LABORATORIES LTD. PARDEEP VERMA VP — CORPORATE AFFAIRS & COMPANY SECRETARY Manufacturing Facilities: Unit I: NH-21, Village Jawaharpur, Tehsil Derabassi, District SAS Nagar (Mohali), Punjab - 140507 Unit II: Phase 1, SIDCO Industrial Growth Centre, Samba, Jammu & Kashmir - 184121 Followus: QOOO @ 0172-2730503, 2730920, 5061851-53 (54 info@indswiftlabs.com @ www.indswiftgroup.com For verifying authenticity of this letter, please reach us by sending copy of same on hr.ho@indswiftlabs.com e RATTAN KAUR & ASS| RATTAN KAUR OCIATES cA B.Com(H), FC.A. CHARTERED ACCOUNTANTS DISA (ICAI), FAFD (ICAI) SCF: 1, SECTOR: 20-C CHANDIGARH: 160029 . Mobile: 950134330 Emaxl:carartan@gmail.com Independent Auditor’s Review Report on the Quarterly Unaudited Standalone Financial Results of Ind-Swift Laboratories Limited pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended). Review Report to The Board of Directors Ind-Swift Laboratories Ltd 1. We have reviewed the accompanying statement of unaudited standalone financial results (the “Statement”) of Ind-Swift Laboratories Ltd. (the” Company”) for the Quarter ended September 30, 2026, being submitted by the company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 as amended (the “Listing Regulations”). The Company's management is responsible for the preparation of the Statement in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, (Ind AS 34) "Interim Financial Reporting" prescribed under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. The Statement has been approved by the Company's Board of Directors. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Institute of Chartered Accountants of India. This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. n Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement prepared in accordance with recognition and measurement principles laid down in the aforesaid Indian Accounting Standards ('Ind AS') specified under section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement. For Rattan Kaur & Associates Chartered Accountants (Regd No: 022513N) Place: Chandigarh Date: 29-10-2026 M. No. 513530 UDIN: 24512830ERR25S5N3 Ind-Swifr Laboraronies Limired IND SWIFT LABORATORIES LTD. Regd Office : SCO 850, Shivalik Enclave, NAC Manimajra, Chandigarh-160101 STATEMENT OF STANDALONE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER & HALF YEAR ENDED 30TH SEPT 2026 CIN 124232CH1995PLCO15553 Rs. In Lakhs STANDALONE Particulars Quarter Ended | Quarter Ended | Quarter Ended | Half Year Ended | Half Year Ended | Vear Ended 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.0.2025 31.03.2026 Unaudited Unaudited Unaudited Unaudited Unaudited Audited Income from Operations: Revenue from operations 23489.06 18608.2¢ 1564333 4209728 3100165 63588.85 Other Income 75987 76282 118631 152269 2085.63 469552 Total Income 2424891 1937106 1682963 43619.97 33087.28 6828437 ExpeNsEs: 2 Cost of Materials Consumed 928619 817264 6591.08 1745883 13035.77 2747047 b purchase of stock in Trade 1605 40 132679 1189.40 293219 205563 376584 < (Increase) /decrease in FG,WIP & stock in trade (287.26) (1978.22) (56.55) (2265.49) (24121 (2890.74) o Employee benefit 373621 389535 357276 763155 677324 13632 80 e Finance Costs 13331 7051 20146 20383 31659 14040 f. Depreciation 77709 758.31 69775 153539 1365.42 305669 . Other expenditure 491576 385933 352805 8775.09 7693.62 16982.90 TOTAL EXPENSES 2016670 1610471 15723.94 3627141 30999.07 62162.06 Profit{loss) before exceptional Items and Tax 208221 326635 110569 734856 208821 612231 Exceptional tems (Income) /loss 5797 2358 0.00 8155 0.00 110064 Profit(ioss) before Tax (After exceptional items) 4024.23 3242.77 1105.69 7267.00 2088.21 502167 Tax Expenses - Current Tax o141 79837 23000 171978 40058 130610 Mat credit Utilisation 0.00 0.00 000 000 000 000 Deferred Tax 000 0.00 000 0.00 000 (540.15) Profit/ (Loss) after tax and before share of 3102.82 2444.40 875.69 5547.22 1667.63 425568 Share of profit (loss) in joint venture 000 000 000 000 000 000 Profit (+)/ Loss (-) for the period from continuing operations 310282 2444.40 875.69 5547.22 1687.63 4255.68 Profit (+)/ Loss (-) from discontinuing operations 0.00 000 000 000 0.00 000 Tax Expense of discounting operations 000 0.00 0100 o0 0.00 000 Profit (+)/ Loss (-) from discontinuing operations{aftTaexr) 000 0.00 0.00 000 000 000 [Net Profit /{ Loss) for the period after tax & Exceptional items) 310282 2444.40| 87569 5547.22 1687.63 4255.68| Other Comprehensive Income [A) tems that will not be reclassified to P/L A/C 0.00) 0.00) 0.0q] 0.00 0.00) 87.45| B) items that will be reclassified into P/L A/ 0.0 0.00) 0.00) 0,00 0.00) 0.00) (Other Comprehensive Income { Loss) for the period , net of [Showing first 8,000 characters — download PDF for full document]